WHO issued interim guidance Wednesday intended to reduce the risk of maternal Zika virus infection and manage any potential complications during pregnancy.
“Although Zika virus infection in pregnancy is typically a mild disease, an unusual increase in cases of congenital microcephaly, Guillain-Barré syndrome and other neurological complications in areas where outbreaks have occurred has significantly raised concern for pregnant women and their families, as well as health providers and policy-makers,” according to WHO.
In addition to listing preventive measures for pregnant women, the guidance also covers diagnosis of pregnant women and care and management for all pregnant women living in affected areas.
See the full guidance here.
More articles on Zika virus:
How Google is working with UNICEF to fight Zika
Pregnant woman is Napa County’s first Zika case
FDA makes recommendations to limit risk of Zika transmission through tissue donation
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
